Jeff Jasper, Ph.D.
SVP, Research

Jeff Jasper, Ph.D. has served as head of Research at Terns since December 2021. He brings more than three decades of biopharmaceutical industry experience across a range of therapeutic areas. Dr. Jasper was most recently Vice President of Research at Rubedo Life Sciences where he oversaw discovery research and nonclinical development targeting underlying biological drivers of chronic diseases. He has held roles at Roche, Theravance, Cytokinetics and Merck and was co-founder of Altos Therapeutics (acquired by Takeda Pharmaceuticals) directed toward gastrointestinal disorders. His experience includes work on discovery teams that have delivered over 20 clinical candidates to IND submission and five programs that yielded FDA-approved medicines.

Dr. Jasper’s professional activities include 20 years as member of the Editorial Board for the American Journal of Physiology: Cell Physiology,12 years instructing “Molecular Pharmacology” for the University of California, Berkeley Extension, and he has published over 50 peer-reviewed scientific articles. He completed his bachelor’s degree in chemistry at California Polytechnic University, San Luis Obispo, his Ph.D. in Pharmacology in the School of Medicine at UC San Diego and his postdoctoral training at Stanford University.